Significantly better glycemic control and weight reduction with liraglutide, a once-daily human GLP-1 analog, compared with insulin glargine: all as add-on to metformin and a sulfonylurea in type 2 diabetes
Clinical Educational Sessions We supported multiple clinical educational presentations coast to coast this quarter, and we're just getting started
That larger effect is precisely why these medicines are prescribed to people who need substantial, clinically meaningful weight reductions to improve health outcomes
Most patients experience the greatest GI impact during the first few weeks after starting treatment or following dose increases
Calocurb should not be taken by individuals that have any form of gastrointestinal inflammation or inflammatory bowel disease, such as Crohn's or ulcerative colitis
Wild-type enzyme and K105X mutants tended to have infinite true k cat and K m values for extrapolated infinite substrate concentrations, suggesting that the enzymes are neither saturated by GSSCys nor GSH (Supplementary Fig